|
| 35948655 | Content and delivery preferences for information to support the management of high blood pressure. | J Hum Hypertens | 2024 |
| 37712135 | Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. | J Hypertens | 2024 |
| 36631562 | The gut microbiome and hypertension. | Nat Rev Nephrol | 2023 |
| 37596052 | Dietary Fiber and Microbiota Metabolite Receptors Enhance Cognition and Alleviate Disease in the 5xFAD Mouse Model of Alzheimer's Disease. | J Neurosci | 2023 |
| 37454911 | Novel mechanisms of salt-sensitive hypertension. | Kidney Int | 2023 |
| 37440367 | Guidelines for microbiome studies in renal physiology. | Am J Physiol Renal Physiol | 2023 |
| 37096822 | Challenging the status quo: a case for the lack of gut microbiota exacerbating hypertensive end-organ damage. | Cardiovasc Res | 2023 |
| 36857894 | A major mechanism for immunomodulation: Dietary fibres and acid metabolites. | Semin Immunol | 2023 |
| 36723455 | Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10â¿¿046 participants of the May Measurement Month campaigns. | J Hypertens | 2023 |
| 34363610 | Rodent models of hypertension. | Br J Pharmacol | 2022 |
| 35838884 | How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure. | Curr Hypertens Rep | 2022 |
| 35674054 | Association Between the Gut Microbiome and Their Metabolites With Human Blood Pressure Variability. | Hypertension | 2022 |
| 35577952 | A roadmap of strategies to support cardiovascular researchers: from policy to practice. | Nat Rev Cardiol | 2022 |
| 35399679 | Reduced Growth, Altered Gut Microbiome and Metabolite Profile, and Increased Chronic Kidney Disease Risk in Young Pigs Consuming a Diet Containing Highly Resistant Protein. | Front Nutr | 2022 |
| 35762848 | Transcriptomic analysis of preovipositional embryonic arrest in a nonsquamate reptile (Chelonia mydas). | Mol Ecol | 2022 |
| 35818678 | Supporting cardiovascular researchers takes a village but it starts with us. | Eur Heart J | 2022 |
| 35861751 | Gut Microbiota: Friends or Foes for Blood Pressure-Lowering Drugs. | Hypertension | 2022 |
| 35745496 | Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies. | Pathogens | 2022 |
| 36048918 | Dysbiosis in Preeclampsia and Treatment With Short Chain Fatty Acids. | Circ Res | 2022 |
| 35257038 | Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients. | JACC Basic Transl Sci | 2022 |
| 35135325 | Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword. | Stroke | 2022 |
| 34453104 | MicroRNA-132 may be associated with blood pressure and liver steatosis-preliminary observations in obese individuals. | J Hum Hypertens | 2022 |
| 32733062 | Diet-related gut microbial metabolites and sensing in hypertension. | J Hum Hypertens | 2021 |
| 33603000 | Plasma lipocalin-2/NGAL is stable over 12Â weeks and is not modulated by exercise or dieting. | Sci Rep | 2021 |
| 33866801 | Renal ACE2 (Angiotensin-Converting Enzyme 2) Expression Is Modulated by Dietary Fiber Intake, Gut Microbiota, and Their Metabolites. | Hypertension | 2021 |
| 34789871 | Reporting guidelines for human microbiome research: the STORMS checklist. | Nat Med | 2021 |
| 34629990 | May Measurement Month 2019: an analysis of blood pressure screening results from Australia. | Eur Heart J Suppl | 2021 |
| 34538100 | Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell-Specific Changes in the Kidney and Increases Blood Pressure. | Hypertension | 2021 |
| 34452845 | The Gut Microbiota and Their Metabolites in Human Arterial Stiffness. | Heart Lung Circ | 2021 |
| 34186061 | Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK Biobank. | Gastroenterology | 2021 |
| 34248679 | Leptin and Melanocortin Signaling Mediates Hypertension in Offspring From Female Rabbits Fed a High-Fat Diet During Gestation and Lactation. | Front Physiol | 2021 |
| 34212778 | The Gut Microbiome of Heart Failure With Preserved Ejection Fraction. | J Am Heart Assoc | 2021 |
| 34315522 | Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial. | Trials | 2021 |
| 34336953 | Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites. | Front Cardiovasc Med | 2021 |
| 34333988 | Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways: A Multisite Analysis of Ambulatory Blood Pressure. | Hypertension | 2021 |
| 34135065 | pH and Proton Sensor GPR65 Determine Susceptibility to Atopic Dermatitis. | J Immunol | 2021 |
| 32286082 | Impact, Strategies, and Opportunities for Early and Midcareer Cardiovascular Researchers During the COVID-19 Pandemic. | Circulation | 2020 |
| 32093510 | Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease. | Circulation | 2020 |
| 33087738 | Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure. | Sci Rep | 2020 |
| 33210116 | The conundrum of the gut microbiome and blood pressure: the importance of studying sex and ethnicity. | Eur Heart J | 2020 |
| 32839116 | Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia. | Heart Lung Circ | 2020 |
| 33012206 | Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications. | Hypertension | 2020 |
| 32213140 | Don't Take It With a Pinch of Salt: How Sodium Increases Blood Pressure via the Gut Microbiota. | Circ Res | 2020 |
| 32385705 | The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure. | Curr Hypertens Rep | 2020 |
| 32238785 | Highlights from the International Society of Hypertension's New Investigators Network during 2019. | J Hypertens | 2020 |
| 32427944 | Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice. | Hypertens Res | 2020 |
| 30531472 | The gut microbiota and blood pressure in experimental models. | Curr Opin Nephrol Hypertens | 2019 |
| 31681017 | Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice. | Front Physiol | 2019 |
| 31679421 | Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension. | Hypertension | 2019 |
| 30122113 | Circulating microRNAs, Vascular Risk, and Physical Activity in Spinal Cord-Injured Subjects. | J Neurotrauma | 2019 |